Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL416969 | 1.00 | SMN1; SMN2 (0.39) | SMN1; SMN2CNR1LMNAALDH1A1HSD17B10 | |
| SCHEMBL5251134 | 0.96 | LMNA (0.42) | CNR1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL11672499 | 0.96 | LMNA (0.42) | CNR1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL11288862 | 0.96 | LMNA (0.42) | CNR1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL11672493 | 0.96 | LMNA (0.42) | CNR1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL2956122 | 0.96 | LMNA (0.42) | CNR1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL531156 | 0.96 | LMNA (0.42) | CNR1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL6448104 | 0.96 | LMNA (0.42) | CNR1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL1207736 | 0.96 | LMNA (0.42) | CNR1LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL9816485 | 0.96 | LMNA (0.42) | CNR1LMNAALDH1A1HSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2321363-B1 | TELECHELIC OLEFIN METATHESIS POLYMERS FROM RENEWABLE FEEDSTOCKS | MATERIA INC (US) | 2020-04-22 | — | — | EP | disclosed |
| US-10202620-B2 | Synthesis of olefinic alcohols via enzymatic terminal hydroxylation | PROVIVI, INC. (US) | 2019-02-12 | — | — | US | disclosed |
| US-20160108436-A1 | SYNTHESIS OF OLEFINIC ALCOHOLS VIA ENZYMATIC TERMINAL HYDROXYLATION | PROVIVI, INC. (US) | 2016-04-21 | — | — | US | disclosed |
| WO-2015176020-A1 | SYNTHESIS OF OLEFINIC ALCOHOLS VIA ENZYMATIC TERMINAL HYDROXYLATION | PROVIVI, INC. (US) | 2015-11-19 | — | — | WO | disclosed |
| CN-102177188-B | Telechelic olefin metathesis polymers from renewable feedstocks | MATERIA INC | 2015-02-25 | — | — | CN | disclosed |
| CN-101925554-B | Shrinkage reducing agent | CONSTR RES & TECH GMBH | 2014-06-18 | — | — | CN | disclosed |
| US-8455698-B2 | Hydroxy- and aldehyde functional compounds | EVONIK DEGUSSA GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-8394996-B2 | Method for producing aldehyde functional compounds | EVONIK DEGUSSA GMBH (DE) | 2013-03-12 | — | — | US | disclosed |
| US-8353983-B2 | Shrinkage reducing agent | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-01-15 | — | — | US | disclosed |
| US-8324334-B2 | Telechelic olefin metathesis polymers from renewable feedstocks | MATERIA, INC. (US) | 2012-12-04 | — | — | US | disclosed |
| EP-2382178-A1 | METHOD FOR PRODUCING ALDEHYDE FUNCTIONAL COMPOUNDS | Evonik Degussa GmbH (DE) | 2011-11-02 | — | — | EP | disclosed |
| CN-102177188-A | Telechelic olefin metathesis polymers from renewable feedstocks | MATERIA INC | 2011-09-07 | — | — | CN | disclosed |
| US-20110198535-A1 | HYDROXY- AND ALDEHYDE FUNCTIONAL COMPOUNDS | EVONIC DEGUSSA GMBH (DE) | 2011-08-18 | — | — | US | disclosed |
| EP-2321363-A1 | TELECHELIC OLEFIN METATHESIS POLYMERS FROM RENEWABLE FEEDSTOCKS | Materia, Inc. (US) | 2011-05-18 | — | — | EP | disclosed |
| EP-2247552-A1 | SHRINKAGE REDUCING AGENT | Construction Research & Technology GmbH (DE) | 2010-11-10 | — | — | EP | disclosed |
| WO-2010084053-A1 | METHOD FOR PRODUCING ALDEHYDE FUNCTIONAL COMPOUNDS | EVONIK DEGUSSA GMBH (DE) | 2010-07-29 | — | — | WO | disclosed |
| WO-2010083934-A1 | HYDROXY- AND ALDEHYDE FUNCTIONAL COMPOUNDS | EVONIK DEGUSSA GMBH (DE) | 2010-07-29 | — | — | WO | disclosed |
| EP-2210870-A1 | Hydroxy and aldehyde functional connections | Evonik Degussa GmbH (DE) | 2010-07-28 | — | — | EP | disclosed |
| WO-2010021740-A1 | TELECHELIC OLEFIN METATHESIS POLYMERS FROM RENEWABLE FEEDSTOCKS | MATERIA, INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| WO-2009095131-A1 | SHRINKAGE REDUCING AGENT | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2009-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160108436-A1 | SYNTHESIS OF OLEFINIC ALCOHOLS VIA ENZYMATIC TERMINAL HYDROXYLATION | CYP2E1, ADH5, CYP1A2 | SMN1; SMN2 4809/4885CNR1 709/4885LMNA 3013/4885 |
| US-10202620-B2 | Synthesis of olefinic alcohols via enzymatic terminal hydroxylation | CYP2E1, ADH5, CYP1A2 | SMN1; SMN2 4809/4885CNR1 709/4885LMNA 3013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.